Polymorphisms in the α1A-adrenoceptor gene do not modify the short- and long-term efficacy of α1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia

BJU International

Volumn 97, Issue 4, 2006, Pages 852-855

  Mochtar, Chaidir A ^a   Laan, Wijnand ^b   Van Houwelingen, Kjeld P ^b   Franke, Barbara ^b   De La Rosette, Jean J M C H ^a   Schalken, Jack A ^b   Kiemeney, Lambertus A L M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 adrenergic receptor; BPH; Outcome; Single nucleotide polymorphism; Treatment

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; TAMSULOSIN; TERAZOSIN; ADRENERGIC RECEPTOR ALPHA(1A); ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRA1A GENE; ADULT; AGED; ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GENE; GENETIC VARIABILITY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PERCEPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; URETHRA OBSTRUCTION; URINE FLOW RATE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; RECEPTORS, ADRENERGIC, ALPHA-1; RISK FACTORS; TREATMENT OUTCOME;

EID: 33644894775     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.05998.x     Document Type: Article

References (23)

1. McVary KT Razzaq A Lee C Venegas MF Rademaker A McKenna KE Growth of the rat prostate gland is facilitated by the autonomic nervous system Biol Reprod 1994 51 99 107
2. Boesch ST Corvin S Zhang J Rogatsch H Bartsch G Klocker H Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist Prostate 1999 39 226 33
3. Boesch ST Dobler G Ramoner R et al. Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cells Prostate Suppl 2000 9 34 41
4. Michel MC Potential Role of [alpha]1-Adrenoceptors in the Aetiology of LUTS Eur Urol Suppl 2002 1 5 13
5. Michel MC Kenny B Schwinn DA Classification of alpha 1-adrenoceptor subtypes Naunyn Schmiedebergs Arch Pharmacol 1995 352 1 10
6. Nasu K Moriyama N Kawabe K et al. Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue Br J Pharmacol 1996 119 797 803
7. Malloy BJ Price DT Price RR et al. Alpha1-adrenergic receptor subtypes in human detrusor J Urol 1998 160 937 43
8. NHLBI Program for Genomic Applications. Genomics of Cardiovascular Development, Adaptation, and Remodeling. Validated SNPs identified by resequencing in ADRA1A. Beth Israel Deaconess Medical Center Available at:. Accessed October 2005
9. Lei B Morris DP Smith MP et al. Novel human alpha (1a) -adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function Naunyn Schmiedebergs Arch Pharmacol 2005 371 229 39
10. Xie HG Kim RB Stein CM Gainer JV Brown NJ Wood AJ Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension Pharmacogenetics 1999 9 651 6
11. Snapir A Koskenvuo J Toikka J et al. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline Clin Sci (Lond) 2003 104 509 20
12. Sofowora GG Dishy V Landau R et al. Alpha 1A-adrenergic receptor polymorphism and vascular response Clin Pharmacol Ther 2004 75 539 45
13. Bolonna AA Arranz MJ Munro J et al. No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response Neurosci Lett 2000 280 65 8
14. Hong CJ Wang YC Liu TY Liu HC Tsai SJ A study of alpha-adrenoceptor gene polymorphisms and Alzheimer disease J Neural Transm 2001 108 445 50
15. Hsu JW Wang YC Lin CC et al. No evidence for association of alpha 1a adrenoceptor gene polymorphism and clozapine-induced urinary incontinence Neuropsychobiology 2000 42 62 5
16. Shibata K Hirasawa A Moriyama N Kawabe K Ogawa S Tsujimoto G Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy Br J Pharmacol 1996 118 1403 8
17. Klotsman M Weinberg CR Davis K Binnie CG Hartmann KE A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH Pharmacogenomics J 2004 4 251 9
18. Djavan B Marberger M A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction Eur Urol 1999 36 1 13
19. Schafer W Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple World J Urol 1995 13 47 58
20. Aso Y and the members of Committee 9 Clinical research criteria In Cockett AT Khoury S Aso Y et al. Proceedings of the 3rd International Consultation on Benign Prostatic Hyperplasia (BPH), Monaco June 26-28, 1995 3rd edn Chapt 9. Jersey Scientific Communication International Ltd. 1996 453 66
21. Emberton M Andriole GL de la Rosette J et al. Benign prostatic hyperplasia: a progressive disease of aging men Urology 2003 61 267 73
22. Glavac D Dean M Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations Hum Mutat 1993 2 404 14
23. Kranse R van Mastrigt R Causes for variability in repeated pressure-flow measurements Urology 2003 61 930 5